CN104640444B - 双肝脏靶向氨基磷酸酯和氨基膦酸酯前药 - Google Patents
双肝脏靶向氨基磷酸酯和氨基膦酸酯前药 Download PDFInfo
- Publication number
- CN104640444B CN104640444B CN201380030061.6A CN201380030061A CN104640444B CN 104640444 B CN104640444 B CN 104640444B CN 201380030061 A CN201380030061 A CN 201380030061A CN 104640444 B CN104640444 B CN 104640444B
- Authority
- CN
- China
- Prior art keywords
- compound
- pharmaceutically acceptable
- acceptable salt
- following formula
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 CCCC(CCC1*C)C1C(C)(C)C Chemical compound CCCC(CCC1*C)C1C(C)(C)C 0.000 description 3
- IPEUGPQCSCVAMI-UHFFFAOYSA-N CC(CN(C=NC1)C2=C1CC(N)NC=N2)OCP([N+]([O-])=O)(O)=O Chemical compound CC(CN(C=NC1)C2=C1CC(N)NC=N2)OCP([N+]([O-])=O)(O)=O IPEUGPQCSCVAMI-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C07H19/207—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide
Abstract
Description
Claims (50)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261689936P | 2012-06-16 | 2012-06-16 | |
US61/689936 | 2012-06-16 | ||
PCT/US2013/032128 WO2013187978A1 (en) | 2012-06-16 | 2013-03-15 | Double-liver-targeting phosphoramidate and phosphonoamidate prodrugs |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104640444A CN104640444A (zh) | 2015-05-20 |
CN104640444B true CN104640444B (zh) | 2016-12-14 |
Family
ID=49758597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201380030061.6A Active CN104640444B (zh) | 2012-06-16 | 2013-03-15 | 双肝脏靶向氨基磷酸酯和氨基膦酸酯前药 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN104640444B (zh) |
WO (1) | WO2013187978A1 (zh) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103665043B (zh) | 2012-08-30 | 2017-11-10 | 江苏豪森药业集团有限公司 | 一种替诺福韦前药及其在医药上的应用 |
US10034893B2 (en) | 2013-02-01 | 2018-07-31 | Enanta Pharmaceuticals, Inc. | 5, 6-D2 uridine nucleoside/tide derivatives |
CN103435672A (zh) * | 2013-04-25 | 2013-12-11 | 刘沛 | 含有取代苄基的新型核苷磷酸酯前药的结构与合成 |
WO2016033164A1 (en) | 2014-08-26 | 2016-03-03 | Enanta Pharmaceuticals, Inc. | Nucleoside and nucleotide derivatives |
WO2016073756A1 (en) | 2014-11-06 | 2016-05-12 | Enanta Pharmaceuticals, Inc. | Deuterated nucleoside/tide derivatives |
US9732110B2 (en) | 2014-12-05 | 2017-08-15 | Enanta Pharmaceuticals, Inc. | Nucleoside and nucleotide derivatives |
UA124966C2 (uk) | 2015-03-06 | 2021-12-22 | Атеа Фармасеутікалс, Інк. | <font face="Symbol">b</font>-D-2'-ДЕЗОКСИ-2'-<font face="Symbol">a</font>-ФТОР-2'-<font face="Symbol">b</font>-C-ЗАМІЩЕНІ-2-МОДИФІКОВАНІ-N<sup>6</sup>-ЗАМІЩЕНІ ПУРИНОВІ НУКЛЕОТИДИ ДЛЯ ЛІКУВАННЯ ВИКЛИКАНИХ HCV ЗАХВОРЮВАНЬ |
CN106188192B (zh) * | 2015-04-29 | 2019-09-10 | 刘沛 | 含d-氨基酸酯的核苷氨基磷酸/膦酸酯衍生物及其医药用途 |
CN106188139B (zh) | 2015-05-29 | 2020-02-18 | 江苏天士力帝益药业有限公司 | 替诺福韦单苄酯磷酸酰胺前药、其制备方法及应用 |
JP6743135B2 (ja) * | 2015-09-02 | 2020-08-19 | アッヴィ・インコーポレイテッド | 抗ウィルス性テトラヒドロフラン誘導体 |
CN106543220A (zh) * | 2015-09-16 | 2017-03-29 | 博瑞生物医药(苏州)股份有限公司 | 氨基磷酸酯化合物及其制备方法和晶体 |
CN106543252A (zh) * | 2015-09-16 | 2017-03-29 | 博瑞生物医药(苏州)股份有限公司 | 核苷氨基磷酸酯类前药的制备方法及其中间体 |
CN106478753A (zh) * | 2015-09-16 | 2017-03-08 | 博瑞生物医药(苏州)股份有限公司 | 一种nuc‑1031单一异构体的制备方法和用途 |
AU2016367237B2 (en) | 2015-12-11 | 2020-12-24 | Laurus Labs Limited | Diastereoselective synthesis of phosphate derivatives and of the gemcitabine prodrug NUC-1031 |
US10987372B2 (en) | 2016-03-11 | 2021-04-27 | Kagoshima University | Anti-hepatoma-virus agent |
CA3010462A1 (en) * | 2016-03-25 | 2017-09-28 | Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. | Uridine phosphoramide prodrug, preparation method therefor, and medicinal uses thereof |
US10202412B2 (en) | 2016-07-08 | 2019-02-12 | Atea Pharmaceuticals, Inc. | β-D-2′-deoxy-2′-substituted-4′-substituted-2-substituted-N6-substituted-6-aminopurinenucleotides for the treatment of paramyxovirus and orthomyxovirus infections |
AU2017324939B2 (en) | 2016-09-07 | 2021-10-14 | Atea Pharmaceuticals, Inc. | 2'-substituted-N6-substituted purine nucleotides for RNA virus treatment |
IL295609B2 (en) | 2017-02-01 | 2023-11-01 | Atea Pharmaceuticals Inc | Nucleotide hemisulfate salt for the treatment of hepatitis C virus |
CN106946960A (zh) * | 2017-03-29 | 2017-07-14 | 郑州泰基鸿诺医药股份有限公司 | 一种吉西他滨前药的晶型、制备方法、用途和药物组合物 |
RU2662160C9 (ru) * | 2017-07-03 | 2018-10-22 | Александрович Иващенко Андрей | Комбинированный лекарственный препарат для терапии вирусных инфекций |
WO2019200005A1 (en) | 2018-04-10 | 2019-10-17 | Atea Pharmaceuticals, Inc. | Treatment of hcv infected patients with cirrhosis |
GB201811169D0 (en) * | 2018-07-06 | 2018-08-29 | Kancera Ab | New compounds |
US10874687B1 (en) | 2020-02-27 | 2020-12-29 | Atea Pharmaceuticals, Inc. | Highly active compounds against COVID-19 |
US20230151049A1 (en) * | 2020-03-23 | 2023-05-18 | Viiv Healthcare Company | Compounds Useful in HIV Therapy |
WO2022182604A1 (en) * | 2021-02-23 | 2022-09-01 | Viiv Healthcare Company | Compounds useful in hiv treatment |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060142238A1 (en) * | 2003-07-21 | 2006-06-29 | Mcguigan Christopher | Chemical compounds |
WO2008142055A2 (en) * | 2007-05-22 | 2008-11-27 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa | Antiviral agents |
US20090169504A1 (en) * | 2006-12-28 | 2009-07-02 | Idenix Pharmaceuticals, Inc | Compounds and Pharmaceutical compositions for the treatment of Viral infections |
US20090306007A1 (en) * | 2004-12-09 | 2009-12-10 | Regents Of The University Of Minnesota | Nucleosides with antiviral and anticancer activity |
CN101918425A (zh) * | 2007-03-30 | 2010-12-15 | 法莫赛特股份有限公司 | 核苷氨基磷酸酯前药 |
WO2012094248A1 (en) * | 2011-01-03 | 2012-07-12 | Nanjing Molecular Research, Inc. | O-(substituted benzyl) phosphoramidate compounds and therapeutic use |
-
2013
- 2013-03-15 CN CN201380030061.6A patent/CN104640444B/zh active Active
- 2013-03-15 WO PCT/US2013/032128 patent/WO2013187978A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060142238A1 (en) * | 2003-07-21 | 2006-06-29 | Mcguigan Christopher | Chemical compounds |
US20090306007A1 (en) * | 2004-12-09 | 2009-12-10 | Regents Of The University Of Minnesota | Nucleosides with antiviral and anticancer activity |
US20090169504A1 (en) * | 2006-12-28 | 2009-07-02 | Idenix Pharmaceuticals, Inc | Compounds and Pharmaceutical compositions for the treatment of Viral infections |
CN101918425A (zh) * | 2007-03-30 | 2010-12-15 | 法莫赛特股份有限公司 | 核苷氨基磷酸酯前药 |
WO2008142055A2 (en) * | 2007-05-22 | 2008-11-27 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa | Antiviral agents |
WO2012094248A1 (en) * | 2011-01-03 | 2012-07-12 | Nanjing Molecular Research, Inc. | O-(substituted benzyl) phosphoramidate compounds and therapeutic use |
Also Published As
Publication number | Publication date |
---|---|
WO2013187978A1 (en) | 2013-12-19 |
CN104640444A (zh) | 2015-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104640444B (zh) | 双肝脏靶向氨基磷酸酯和氨基膦酸酯前药 | |
US9156874B2 (en) | Double-liver-targeting phosphoramidate and phosphonoamidate prodrugs | |
CN103403014B (zh) | O-(经取代的苯甲基)氨基磷酸酯化合物及其治疗用途 | |
CN100528173C (zh) | 4′-取代的核苷 | |
CN101031306B (zh) | 作为抗hiv剂的核苷膦酸酯缀合物 | |
US6875751B2 (en) | 3′-prodrugs of 2′-deoxy-β-L-nucleosides | |
CN104955818B (zh) | 核苷激酶旁路组合物和方法 | |
BR112020018209A2 (pt) | Composições farmacêuticas, recipiente pressurizado, e, métodos para tratar ou prevenir uma infecção viral e para tratar ou prevenir um coronavírus humano, coronavírus sars, coronavírus mers, vírus da encefalite equina oriental, vírus da encefalite equina ocidental, vírus da encefalite equina venezuelana, vírus da chicungunha, vírus ross river, rsv, vírus influenza a, vírus influenza b, vírus tacaribe, vírus pichinde, vírus junin, vírus da febre lassa, vírus da cariomeningite linfocitária, vírus da febre rift valley, vírus punta toro, vírus lacrosse, vírus maporal, vírus heartland, e vírus da síndrome de trombocitopenia de febre severa, poliovírus, vírus de coxsackie, infecção de norovírus ou enterovírus em um paciente | |
CN101243096B (zh) | 抗病毒化合物 | |
JP6769000B2 (ja) | 4’−チオヌクレオシドの新規な化合物、並びにその調製方法、その医薬組成物及びその用途 | |
KR20030032967A (ko) | 2'-데옥시-β-L-뉴클레오시드의 3'-프로드럭 | |
JP5198055B2 (ja) | ウイルス感染治療用薬学的組成物における活性成分として有用なホスホン酸ヌクレオシド、およびそれらを生産するための中間体 | |
CN106188192B (zh) | 含d-氨基酸酯的核苷氨基磷酸/膦酸酯衍生物及其医药用途 | |
BRPI0709127A2 (pt) | 2'-fluoronucleosìdeo fosfonatos como agentes antivirais | |
JP2006524711A (ja) | 抗ウイルス性ホスホネート類似物 | |
IL217228A (en) | Compounds of Type 2'-Deoxy-2'-Fluoro-2'-c-Methyluridine Nucleoside Phosphoramide Compounds | |
CN107427530A (zh) | 用于HCV治疗的β‑D‑2’‑脱氧‑2’α‑氟‑2’‑β‑C‑取代的‑2‑改性的‑N6‑取代的嘌呤核苷酸 | |
AU2004233989A1 (en) | Anti-cancer phosphonate analogs | |
CN104119385B (zh) | 核苷类似物的磷酸酯前药及其应用 | |
WO2015101183A1 (zh) | 尿嘧啶核苷酸类似物及其制备方法和应用 | |
CN1216893C (zh) | 具有抗乙型肝炎病毒活性的核苷 | |
CN109689063A (zh) | 含有炔烃的核苷酸和核苷治疗组合物及其相关用途 | |
BR112016008934B1 (pt) | Pró-fármaco mútuo compreendendo ácidos graxos de cadeia curta e zebularina ou 1- ciano-citarabina para tratamento de câncer, e uso do referido pró-fármaco | |
CN107820499A (zh) | 新的抗病毒化合物、其制备工艺、以及其用于治疗病毒感染的用途 | |
CN101511185A (zh) | 唑类核苷和作为rna和dna病毒聚合酶抑制剂的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160201 Address after: 451162, Zhengzhou Zhengzhou air port, four port linkage Avenue and 102 provincial highway intersection, Zhengzhou Taiwan science and Technology Park, building A07, Henan Applicant after: Henan Meitaibao Bio-Pharmaceutical Co., Ltd Address before: The spring road in Qixia District of Nanjing City, Jiangsu Province, No. 18 210028 Applicant before: Nanjing Molecular Research, Inc |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190313 Address after: 467036 No. 10 Inner Courtyard Building, Fuxing Road Middle Section, Pingdingshan City, Henan Province Patentee after: Henan real biological science and Technology Co Ltd Address before: 451162 Zhengzhou Airport District, Zhengzhou City, Henan Province, Intersection of Four Ports Linkage Avenue and 102 Provincial Highway A07 Building, Zhengzhou Taiwan Science Park Patentee before: Henan Meitaibao Biological Pharmaceutical Co., Ltd. |
|
TR01 | Transfer of patent right |